Abstract
AbstractCYM 50333 (I) and CYM 50367 (II), novel selective S1P4 antagonists with activities in the nanomolar range, represent valuable small molecule tools to investigate the biological and pharmacological role of the target receptor in megakaryocyte differentiation and fundamental immune processes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
